Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles

被引:191
作者
Avgoustakis, K [1 ]
Beletsi, A
Panagi, Z
Klepetsanis, P
Livaniou, E
Evangelatos, G
Ithakissios, DS
机构
[1] Univ Patras, Pharmaceut Technol Lab, Dept Pharm, Patras 26500, Greece
[2] NCSR Demokritos, Inst Radioisotopes & Radiodiagnost Prod, Athens 15310, Greece
关键词
poly(lactide-co-glycolide)-(polyethyleneglycol) nanoparticles; biodistribution; blood clearance; copolymer composition; colloidal stability;
D O I
10.1016/S0378-5173(03)00224-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The physicochemical properties, the colloidal stability in vitro and the biodistribution properties in mice of different PLGA-mPEG nanoparticle compositions were investigated. The nanoparticles were prepared by a precipitation-solvent evaporation technique. The physical characteristics and the colloidal stability of the PLGA-mPEG nanoparticles were significantly influenced by the composition of the PLGA-mPEG copolymer used to prepare the nanoparticles. PLGA-mPEG nanoparticles prepared from copolymers having relatively high mPEG/PLGA ratios were smaller and less stable than those prepared from copolymers having relatively low mPEG/PLGA ratios. All PLGA-mPEG nanoparticle compositions exhibited prolonged residence in blood, compared to the conventional PLGA nanoparticles. The composition of the PLGA-mPEG copolymer affected significantly the blood residence time and the biodistribution of the PLGA-mPEG nanoparticles in liver, spleen and bones. The in vivo behavior of the different PLGA-mPEG nanoparticle compositions did not appear to correlate with their in vitro stability. Optimum mPEG/PLGA ratios appeared to exist leading to long blood circulation times of the PLGA-mPEG nanoparticles. This may be associated with the effects of the mPEG/PLGA ratio on the density of PEG on the surface of the nanoparticles and on the size of the nanoparticles. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:115 / 127
页数:13
相关论文
共 28 条
[1]   PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Karydas, AG ;
Ithakissios, DS .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :123-135
[2]   STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM [J].
BAZILE, D ;
PRUDHOMME, C ;
BASSOULLET, MT ;
MARLARD, M ;
SPENLEHAUER, G ;
VEILLARD, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :493-498
[3]   Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide) methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery [J].
Beletsi, A ;
Leontiadis, L ;
Klepetsanis, P ;
Ithakissios, DS ;
Avgoustakis, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (02) :187-197
[4]   PREPARATION OF TC-99M LABELED PYRIDOXAL-AMINO ACID COMPLEXES AND THEIR EVALUATION [J].
CHIOTELLIS, E ;
SUBRAMANIAN, G ;
MCAFEE, JG .
INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE & BIOLOGY, 1977, 4 (01) :29-41
[5]   Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles:: Influence on physical stability and in vitro cell uptake [J].
De Jaeghere, F ;
Allémann, E ;
Leroux, JC ;
Stevels, W ;
Feijen, J ;
Doelker, E ;
Gurny, R .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :859-866
[6]   In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers [J].
Dunn, SE ;
Coombes, AGA ;
Garnett, MC ;
Davis, SS ;
Davies, MC ;
Illum, L .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (01) :65-76
[7]  
Emile C, 1996, Drug Deliv, V3, P187, DOI 10.3109/10717549609029449
[8]   Defining the drug incorporation properties of PLA-PEG nanoparticles [J].
Govender, T ;
Riley, T ;
Ehtezazi, T ;
Garnett, MC ;
Stolnik, S ;
Illum, L ;
Davis, SS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (01) :95-110
[9]   THE CONTROLLED INTRAVENOUS DELIVERY OF DRUGS USING PEG-COATED STERICALLY STABILIZED NANOSPHERES [J].
GREF, R ;
DOMB, A ;
QUELLEC, P ;
BLUNK, T ;
MULLER, RH ;
VERBAVATZ, JM ;
LANGER, R .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :215-233
[10]   BIODEGRADABLE LONG-CIRCULATING POLYMERIC NANOSPHERES [J].
GREF, R ;
MINAMITAKE, Y ;
PERACCHIA, MT ;
TRUBETSKOY, V ;
TORCHILIN, V ;
LANGER, R .
SCIENCE, 1994, 263 (5153) :1600-1603